Cancer News and Research

Latest Cancer News and Research

PTEN does not reduce effectiveness of breast cancer drug, Herceptin: Study

Contrary to what many oncologists had thought, a tumor suppressor protein known as PTEN does not reduce the effectiveness of the breast cancer drug Herceptin, according to a study by Mayo Clinic and North Central Cancer Research Group investigators.

4 Jun 2011

Key findings from Phase I clinical trial of CPI-613 in AML to be presented at ASCO 2011

Cornerstone Pharmaceuticals and Wake Forest Baptist Medical Center today announced key findings from a Phase I clinical trial of Cornerstone's first-in-class cancer metabolism inhibitor drug, CPI-613 in Acute Myeloid Leukemia.

4 Jun 2011

Response Genetics' clinical approaches to improve cancer care to be presented at ASCO 2011

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced today five presentations to be held during the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL from June 3 to June 7, 2011.

4 Jun 2011

Decreasing iron-storing protein expression can enhance action of brain cancer therapy: Researchers

Brain cancer therapy may be more effective if the expression of an iron-storing protein is decreased to enhance the action of therapeutic drugs on brain cancer cells, according to Penn State College of Medicine researchers.

4 Jun 2011

U of Alberta researchers win Canadian Society of Chemistry award

A one-of-a-kind Canadian research group, based in the Faculty of Medicine & Dentistry at the University of Alberta, has now won every award handed out by the Canadian Society of Chemistry for analytical and environmental chemistry.

4 Jun 2011

Roche, Bristol-Myers Squibb to evaluate YERVOY and vemurafenib treatment for metastatic melanoma

Bristol-Myers Squibb Company announced today it has entered in to a clinical collaboration agreement with Roche to evaluate the utility of Bristol-Myers Squibb's CTLA-4 inhibitor, YERVOY (ipilimumab), in combination with Roche's investigational oral BRAF inhibitor, vemurafenib, in treating patients with a specific type of metastatic melanoma.

4 Jun 2011

Hospitals need to measure quality of care

Hospitals that provide quality care for young people do not always provide the same quality care for the elderly, a new study has found.

4 Jun 2011

FSU assistant professor unlocks mysteries of KSHV infection

In the early days of the AIDS epidemic, a once-rare form of cancer known as Kaposi's sarcoma emerged as a frequent harbinger of HIV. Its stigma was best illustrated by Tom Hanks, who portrayed a gay man trying to conceal the cancerous skin lesions from his co-workers in the 1993 movie "Philadelphia."

4 Jun 2011

Research roundup: More spending can lead to better care; Calif. exchange lessons; high-volume hospitals

Medical Spending And The Health Of The Elderly -- Does more medical spending lead to better health care for people over age 64? To answer that question, "researchers from George Mason University and the Urban Institute used data of 17,438 elderly who entered the Medicare Current Beneficiary Survey in the fall of each year from 1991 to 1999, and conducted multiple interviews over three years," according to one description of the study.

4 Jun 2011

Princess Margaret Hospital Foundation, Canadian Cancer Society to raise funds towards conquering cancer

A landmark partnership announced today between Canada's two largest cancer charities, The Princess Margaret Hospital Foundation and the Canadian Cancer Society, will raise significant amounts of money towards conquering cancer through the national expansion of Road Hockey to Conquer Cancer.

4 Jun 2011

Battelle, Perma-Fix sign exclusive option agreement to make medical isotopes

Perma-Fix Environmental Services, Inc. today announced it has signed an exclusive option agreement with Battelle, which operates Pacific Northwest National Laboratory for the U.S. Department of Energy, to license technology from PNNL for use with Perma-Fix's proprietary process to safely and cost-effectively produce Molybdenum-99 (Mo-99), which is used to make Technetium 99m (Tc-99m).

4 Jun 2011

Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer

A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology.

4 Jun 2011

Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators.

4 Jun 2011

Nuvera announces results of blinded study on breast cancer assay for taxane chemotherapy response

Nuvera Biosciences, a molecular diagnostics company that develops gene-based diagnostic assays for personalized medicine in cancer, announced the results of a blinded validation study on its breast cancer assay for taxane chemotherapy response.

4 Jun 2011

NIH approves BioTime's two human embryonic stem cell lines for clinical use

BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.

4 Jun 2011

Cancer vaccine shows improved response rate in patients

A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to research led by scientists from The University of Texas MD Anderson Cancer Center and Indiana University Health Goshen Center for Cancer Care.

3 Jun 2011

National Cancer Survivors Day to be held on June 5th 2011

The 24th National Cancer Survivors Day will be held on June 5th this year. "This annual event is a national recognition that we have made significant progress in the fight against cancer," said Dr. Patricia Robinson, director of Loyola University Health System's Cancer Survivorship Program. Robinson sees cancer survivors at Loyola's main campus in Maywood and at the Loyola Center for Health at Wheaton.

3 Jun 2011

Cancer News and Research

Latest Cancer News and Research

PTEN does not reduce effectiveness of breast cancer drug, Herceptin: Study

Key findings from Phase I clinical trial of CPI-613 in AML to be presented at ASCO 2011

Response Genetics' clinical approaches to improve cancer care to be presented at ASCO 2011

Decreasing iron-storing protein expression can enhance action of brain cancer therapy: Researchers

U of Alberta researchers win Canadian Society of Chemistry award

Roche, Bristol-Myers Squibb to evaluate YERVOY and vemurafenib treatment for metastatic melanoma

Hospitals need to measure quality of care

FSU assistant professor unlocks mysteries of KSHV infection

Research roundup: More spending can lead to better care; Calif. exchange lessons; high-volume hospitals

Princess Margaret Hospital Foundation, Canadian Cancer Society to raise funds towards conquering cancer

Battelle, Perma-Fix sign exclusive option agreement to make medical isotopes

Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer

Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

Nuvera announces results of blinded study on breast cancer assay for taxane chemotherapy response

NIH approves BioTime's two human embryonic stem cell lines for clinical use

Cancer vaccine shows improved response rate in patients

National Cancer Survivors Day to be held on June 5th 2011

Delayed treatment could prove effective in certain medical conditions

Bexarotene and erlotinib drugs effective in treating advanced lung cancer

Mimicry allows bacteria to evade host's defense responses

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in